Earnings Release • Jul 26, 2012
Earnings Release
Open in ViewerOpens in native device viewer
Commenting on the figures, Mr Jean-Paul Agon, Chairman and CEO of L'Oréal, said:
"L'Oréal recorded a good first half. In a market which reflects contrasting trends but is favourable overall, all branches, divisions and geographic zones achieved growth.
L'Oréal Luxe is confirming its very good performance, thanks to the major successes of Lancôme, Yves Saint Laurent, Kiehl's and the Designer Fragrances. Active Cosmetics is accelerating significantly, driven by its international dynamics. The Consumer Products Division has achieved solid growth. The rejuvenation of The Body Shop is generating more substantial growth.
The rise of the New Markets, now our number one geographic zone, is continuing, driven by the dynamism of Asia and Africa, Middle East. North America is growing fast, with large market share gains and the strategic acquisition of Clarisonic. Eastern Europe is continuing its recovery, and the group is improving its positions in the major countries of Western Europe.
The first half confirms the relevance of our strategic thrusts, and the innovative power of L'Oréal. Our initiatives plan is solid.
Despite the uncertain economic environment, we are confident in the group's ability to outperform the market in 2012, and to achieve another year of solid growth in both sales and profits."
www.loreal.com - Follow us on twitter @Loreal
Like-for-like, i.e. based on a comparable structure and identical exchange rates, the sales growth of the L'Oréal group was +6.0%.
The net impact of changes in consolidation was +0.7%.
Currency fluctuations had a positive impact of 3.8%. If the exchange rates at June 29th, 2012, i.e. €1 = \$1.2683, are extrapolated up to December 31st, the impact of currency fluctuations on sales would be approximately +4.2% for the whole of 2012.
Growth at constant exchange rates was +6.7%.
Based on reported figures, the group's sales at June 30th, 2012 amounted to 11.21 billion euros, an increase of +10.5%.
| nd quarter 2012 2 |
st half 2012 1 |
|||||
|---|---|---|---|---|---|---|
| Growth | Growth | |||||
| €m | Like-for-like | Reported | €m | Like-for-like | Reported | |
| By operational division | ||||||
| Professional Products | 767.9 | 2.7% | 9.0% | 1,523.4 | 2.9% | 7.3% |
| Consumer Products | 2,675.7 | 4.2% | 9.1% | 5,445.2 | 4.7% | 8.1% |
| L'Oréal Luxe | 1,336.1 | 8.7% | 17.9% | 2,651.5 | 10.4% | 17.9% |
| Active Cosmetics | 382.1 | 6.4% | 8.4% | 850.7 | 5.4% | 6.6% |
| Cosmetics total | 5,161.8 | 5.3% | 11.1% | 10,470.9 | 5.9% | 10.2% |
| By geographic zone | ||||||
| Western Europe | 1,883.2 | -0.1% | 1.5% | 3,837.2 | 0.8% | 1.9% |
| North America | 1,307.8 | 7.9% | 22.7% | 2,571.2 | 7.3% | 17.8% |
| New Markets, of which: | 1,970.8 | 9.1% | 14.4% | 4,062.5 | 10.2% | 14.2% |
| - Asia, Pacific | 1,006.6 | 9.2% | 21.1% | 2,130.9 | 12.5% | 21.9% |
| - Eastern Europe | 338.1 | 4.3% | 3.9% | 698.2 | 3.1% | 2.7% |
| - Latin America | 448.3 | 7.9% | 5.0% | 881.8 | 8.2% | 6.2% |
| - Africa, Middle East | 177.8 | 23.5% | 27.5% | 351.6 | 17.2% | 18.2% |
| Cosmetics total | 5,161.8 | 5.3% | 11.1% | 10,470.9 | 5.9% | 10.2% |
| The Body Shop | 193.5 | 7.0% | 15.3% | 373.9 | 5.4% | 10.8% |
| Dermatology(1) | 214.9 | 14.3% | 21.0% | 368.4 | 11.0% | 19.9% |
| Group total | 5,570.2 | 5.7% | 11.6% | 11,213.2 | 6.0% | 10.5% |
(1) Group share, i.e. 50%.
The Professional Products Division posted growth of +2.9% like-for-like and +7.3% based on reported figures. The first-half highlight was the division's good performance in the New Markets, particularly in Asia and Eastern Europe.
The Consumer Products Division achieved sales growth of +4.7% like-for-like, and +8.1% based on reported figures, and made substantial market share gains in Western Europe and North America.
L'Oréal Paris confirmed the success of Elvive Triple Resist enriched with Arginine and has launched Elvive ExtraOrdinary Oil. In make-up, Rouge Caresse lipstick has made a very good start, and the same is true of Color Riche nail varnish. The Youth Code Luminize and Revitalift BB Cream skincare lines are boosting facial skincare sales.
At Garnier, Miracle Skin Perfector (BB Cream) is continuing its spectacular success in Europe, and now in North America. Already a big hit in the United States, Dark Spot Corrector skincare is arriving in Europe. Ultra Doux and Fructis dry shampoos have made a promising start.
For Maybelline, the first half has been marked by the launch of the new Superstay 14hr One Step lipstick technology in the United States and Fit me foundations in Europe.
In Western Europe, in a flat market, the division is making significant market share gains, particularly in France, Germany, Italy and the Scandinavian countries.
In North America, the division recorded strong growth in all categories.
In the New Markets, all the regions are achieving positive growth.
Eastern Europe has returned to growth, thanks to the new hair colourant Color Sensation and BB cream, both from Garnier, and to L'Oréal Paris Elvive Triple Resist enriched with Arginine haircare. In Latin America, the division is confirming the dynamic sales trend in Mexico, Argentina and Chile, but is suffering from a highly competitive market in Brazil.
Asia, Pacific is recording good scores in China, Thailand and Indonesia. Australia was affected by a one-off operational problem.
Finally, the Africa, Middle East zone is growing strongly.
Sales of the L'Oréal Luxe Division increased by +10.4% like-for-like. Growth based on reported figures came out at +17.9%, reflecting the impact of the acquisition of Clarisonic. L'Oréal Luxe is growing in all categories, and is making substantial market share gains.
Lancôme had a very good first half, particularly in facial skincare with its two serums Génifique and Visionnaire, and the new and highly exclusive Absolue L'Extrait. In make-up, Rouge in love, and the long-lasting foundation Teint Idole Ultra 24h are continuing to prove successful.
At Yves Saint Laurent, the strategic launch of Forever Youth Liberator facial skincare is driving the brand's growth in Asia. Rouge Pur Couture lip varnish has been acknowledged as a major innovation.
Giorgio Armani strengthened its position in men's fragrances with the launch of Acqua di Giò Essenza, and continued its strategic advances in make-up and facial skincare.
Kiehl's is continuing its rapid growth on all continents. Clearly Corrective, a great innovation in antiblemish skincare, has had a very good start.
The Designer Fragrance brands had a very good first half: Ralph Lauren with The Big Pony Fragrance Collection for Women, Viktor & Rolf with Flowerbomb, and Spicebomb, one of this year's biggest hits in men's products.
Clarisonic, acquired in December, continued to grow strongly in the United States.
In Western Europe, in a slightly negative market, the division is advancing and winning market share, particularly in France, Germany and the United Kingdom, thanks to Lancôme, Yves Saint Laurent, Kiehl's and Diesel.
In North America, L'Oréal Luxe recorded strong growth, driven by Clarisonic, Yves Saint Laurent, Ralph Lauren and Kiehl's, along with Viktor & Rolf.
In the New Markets, the division achieved very strong growth, particularly in Asia where market share gains were significant. Lancôme is proving highly dynamic there, along with Yves Saint Laurent and Helena Rubinstein. Giorgio Armani is growing in the Middle East, with its premium fragrance line Armani Privé. In Latin America, Ralph Lauren is proving highly successful with The Big Pony Collection for Women and Kiehl's is continuing its roll-out, particularly in Brazil. The division's sales in Travel Retail are dynamic.
In the first half, the Active Cosmetics Division delivered growth of +5.4% like-for-like and +6.6% based on reported figures. The division's sales are accelerating in North America and the New Markets.
In a flat to slightly negative market, L'Oréal recorded positive sales growth at +0.8% like-for-like and +1.9% based on reported figures. This figure reflects contrasting trends, with good scores in the United Kingdom, France, Germany and Travel Retail and negative trends in the countries of Southern Europe.
In North America, L'Oréal achieved growth of +7.3% like-for-like and +17.8% based on reported figures in the first half of 2012. L'Oréal Luxe made a very good start to the year, thanks to Yves Saint Laurent, the launch of The Big Pony Fragrance Collection for Women by Ralph Lauren and the integration of Clarisonic. The Consumer Products Division continued to make market share gains, particularly with Maybelline, L'Oréal Paris and Essie in make-up, and Garnier in facial skincare. The Professional Products Division is growing faster than the market, thanks to the good scores of Kérastase and the relaunch of Pureology. The Active Cosmetics Division is continuing its breakthrough in the United States, driven by SkinCeuticals.
At end-June 2012, the New Markets recorded growth of +10.2% like-for-like and +14.2% based on reported figures.
At end-June, The Body Shop recorded like-for-like growth at +5.4% and +10.8% based on reported figures.
The Body Shop is growing strongly in the New Markets, particularly in South-East Asia where the dynamic sales trend is continuing in India and Indonesia, and sales are accelerating in Russia and in Saudi Arabia. In the developed countries, the brand is feeling the impact of the tough environment in Southern Europe, but its performance in Northern Europe has been solid.
The brand has continued to recruit new customers and accelerate its development in e-commerce, and now has 20 online sales sites.
The Body Shop is continuing its policy of sensorial innovations and militant launches, with Beauty Oils, a range of bodycare oils with Community Fair Trade ingredients, and a new capsule collection created with Lily Cole for her "zero cruelty" make-up line.
In addition, the brand is successfully continuing the international roll-out of Pulse, its innovative store concept, focused on story-selling and a highly interactive consumer experience.
At June 30th, 2012, The Body Shop has a total of 2,781 stores.
Galderma's sales increased by +11.0% like-for-like, and +19.9% based on reported figures. Oracea (rosacea), Azzalure (muscle relaxant for frown lines) and Cetaphil recorded very strong growth.
The Asia, Pacific and Latin America zones, with double-digit growth, were the main contributors to sales growth in the first half. Growth was particularly strong in Brazil and South Korea, where the product ranges in Galderma's three fields of activity (prescription drugs, OTC drugs and aesthetic and corrective products) are proving highly successful with health professionals.
The situation in Europe reflected more marked contrasts, as the economic environment has not been conducive to growth in aesthetic and corrective products. Germany achieved strong growth, thanks to the very good performance of Loceryl (an over-the-counter treatment for nail mycosis).
In North America, growth was strong in Canada, thanks in particular to the launch of Epiduo (acne). In the United States, the good performances of Epiduo and Oracea partly offset the impact on growth of the arrival on the market of generics of Clobex lotion and shampoo (psoriasis).
On April 26th, 2012, L'Oréal closed the acquisition of 100% of Cadum, the majority of which had been held by investment fund Milestone.
Cadum, which mainly markets hygiene and toiletry products, achieved consolidated sales of 58 million euros, mainly with the brand Cadum. This new business has joined France's Consumer Products Division.
On July 13th, 2012, L'Oréal announced that it has completed the sale of the home care business from the Cadum Group to Eau Ecarlate SAS. This business achieved a turnover of 17 million euros in 2011, two thirds of which in France.
"This news release does not constitute an offer to sell, or a solicitation of an of fer to buy L'Oréal shares. If you wish to obtain more c omprehensive information about L'Oréal, please refer to t he public documents registered in France with t he Aut orit é des Marchés Financiers, als o available in English on our Int ernet site www.loreal-finance.com.
This news release may contain s ome forward -looking statements. Although t he Company considers t hat these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nat ure subject to risks and uncertainties which could cause actual results to differ mat erially from those indicat ed or projected in these statements."
Contacts at L'ORÉAL (Switchboard: +33 1 47 56 70 00)
Individual shareholders Financial analysts and
Tel: +33 1 47 56 83 02 Tel: +33 1 47 56 86 82 Tel: +33 1 47 56 76 71
and market authorities Institutional investors Journalists
Mr Jean Régis CAROF Mrs Françoise LAUVIN Mrs Stephanie CARSON-PARKER [email protected] [email protected] [email protected]
For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult yo ur usual newspapers, and the Internet site for shareholders and investors, http://www.loreal-finance.com, or its mobile version on your cell phone, http://loreal-finance.mobi; alternatively, call +33 1 40 14 80 50.
| 2011 | 2012 | |
|---|---|---|
| First quarter: | ||
| Cosmetics | 4,861 | 5,309 |
| The Body Shop | 170 | 180 |
| Dermatology | 130 | 154 |
| First quarter total | 5,160 | 5,643 |
| Second quarter: | ||
| Cosmetics | 4,644 | 5,162 |
| The Body Shop | 168 | 194 |
| Dermatology | 177 | 215 |
| Second quarter total | 4,989 | 5,570 |
| First half: | ||
| Cosmetics | 9,505 | 10,471 |
| The Body Shop | 337 | 374 |
| Dermatology | 307 | 368 |
| First half total | 10,150 | 11,213 |
| Third quarter: | ||
| Cosmetics | 4,600 | |
| The Body Shop | 166 | |
| Dermatology | 172 | |
| Third quarter total | 4,938 | |
| Nine months: | ||
| Cosmetics | 14,105 | |
| The Body Shop | 503 | |
| Dermatology | 479 | |
| Nine months total | 15,087 | |
| Fourth quarter: | ||
| Cosmetics | 4,766 | |
| The Body Shop | 264 | |
| Dermatology | 226 | |
| Fourth quarter total | 5,256 | |
| Full year | ||
| Cosmetics | 18,871 | |
| The Body Shop | 768 | |
| Dermatology | 705 | |
| Full year total | 20,343 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.